-

Herbalife Welcomes Back Michael Levitt to Board of Directors

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, today announced the appointment of veteran finance executive, Michael Levitt, to its Board of Directors, effective March 1, 2024. Levitt previously served on the Company’s Board as the Lead Director from 2011 to 2014. Kevin Jones, who has served as a director since 2021, will step down from his role on the Board.

“We are honored to welcome Michael back to our Board,” said Michael Johnson, Chairman and CEO of Herbalife. “Michael’s deep financial expertise, understanding of our business and shared passion for Herbalife’s vision will further strengthen our Board.”

Levitt is the Chairman of Irradiant Partners, LP, an investment management firm. He also serves as a member of the firm’s Management and Investment Committees. Prior to the launch of Irradiant Partners, he held various executive and leadership roles at several investment firms, including Kayne Anderson Capital Advisors, LP, Apollo Global Management, LLC, Smith Barney Inc. and Morgan Stanley & Co. Levitt has also served on multiple board of director positions.

“It is with great enthusiasm that I return to Herbalife’s Board of Directors during a transformational time in the Company’s history and look forward to being a part of its future growth,” said Levitt.

The Company and its Board of Directors extend sincere appreciation to Kevin Jones for his board service, valuable perspective, leadership, and commitment to Herbalife.

For more information, visit https://ir.herbalife.com/.

About Herbalife Ltd.

Herbalife (NYSE: HLF) is a premier health and wellness company and community that has been changing people’s lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life.

Contacts

Thien Ho
Thienh@herbalife.com
213-745-0408

Herbalife Ltd.

NYSE:HLF

Release Versions

Contacts

Thien Ho
Thienh@herbalife.com
213-745-0408

More News From Herbalife Ltd.

Herbalife Announces Pricing of $800 Million Aggregate Principal Amount of Senior Secured Notes Offering

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) (the “Company”), a global health and wellness company, today announced the pricing of the previously announced offering, by HLF Financing SaRL, LLC and Herbalife International, Inc. (together, the “Issuers”), each a wholly owned subsidiary of the Company, of $800 million aggregate principal amount of senior secured notes due 2033 (the “Notes”) at a price to the public of 100.00% of par. The Notes have a fixed annual interest rate of 7.750...

Herbalife Announces Proposed Offering of $800 Million Aggregate Principal Amount of Senior Secured Notes

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) (the “Company”), a global health and wellness company, today announced that HLF Financing SaRL, LLC and Herbalife International, Inc. (together, the “Issuers”), each a wholly owned subsidiary of the Company, intend, subject to market and other conditions, to offer $800 million aggregate principal amount of senior secured notes due 2033 (the “Notes”). The Company expects to use the net proceeds from the offering, together with proceeds fro...

Herbalife Provides Preliminary Q1 2026 Results: Net Sales Above Guidance, Adjusted EBITDA1 Expected At or Above High End of Guidance; Provides Update on Senior Secured Debt Refinancing Plans

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced preliminary first quarter 2026 results. The Company expects: Net sales growth of 7.5% to 8.0% year-over-year, exceeding the high end of previously issued first quarter guidance Net sales growth on a constant currency basis2 of 5.0% to 5.5% year-over-year, above the high end of previously issued first quarter guidance; and Adjusted EBITDA¹ on a reported basis a...
Back to Newsroom